Dr Simon Mitchell

Partner - Patents

  • BSc (1st Class Hons) Neuroscience — Parke Davis Prize in Neuroscience — University of Aberdeen
  • PhD in Biophysics and Pharmacology — University College London
  • PG Certificate (Distinction) in Intellectual Property — Bournemouth University
  • Postdocs in cellular, molecular and computational neuroscience at University College London, Cornell Medical College in New York and MRC Laboratory of Molecular Biology in Cambridge, UK
  • Chartered Patent Attorney/European Patent Attorney
  • UK Legal 500 recommended lawyer 2022
  • Managing Intellectual Property (IP Stars) notable practitioner 2021
  • IAM Patent 1000 Recommended 2021

Simon advises a growing number of direct multinational clients and significant foreign attorney firms in respect of patent application drafting, filing and prosecution, registered design filing and prosecution, contentious matters (e.g. oppositions, revocations) and advisory work.

His expertise focuses in the fields of human health, animal health and food security, and includes pharmaceutical, biotechnological, chemical and mechanical inventions. Specific areas of life sciences expertise include medicinal chemistry; biologics such as therapeutic peptides and proteins, including vaccines and antibodies; diagnostic methods; oligonucleotide therapeutics and probes for diagnosis and treatment, e.g. siRNA, miRNA; genetically-encoded reporter and cell-sorting systems; stem cells; microbiome-related inventions; medical devices; agriculture; and plant varieties.

Simon’s human and animal health patent cases include those relating to cancer, pain, inflammation, infection, epilepsy, migraine, tinnitus, diabetes, multiple sclerosis, Parkinson’s disease, respiratory diseases, eye disorders, genetics-based diagnostics and treatments, sea lice treatments and digestive disorders.

Before joining the profession, Simon worked as postdoctoral researcher at University College London, the Biochemistry Department of Cornell Medical College in New York and the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK.

The focus of his academic research was the pharmacology, biophysics and biochemistry of synaptic transmission, which used electrophysiological, mechano-optical-photonic, genetic, biochemical and computational methods. His research was published in high-profile journals such as Nature, Nature Neuroscience, Neuron and the Journal of Neuroscience.

Simon is recommended in the Legal 500 2017, which stated that he’s a key figure at UDL. Simon was singled out for “in-depth scientific knowledge, pragmatic advice and flexibility”, as part of a patent team praised for its “ability and willingness to dedicate resource when required to support urgent issues” and for its “extremely high” level of service.

He is also recommended in the Legal 500 2018/2019, particularly in respect of his EPO opposition practice, and the IAM Patent 1000 2019 in respect of producing “flawless drafts, time and time again”.

The Legal 500 2020 recommends Simon as a key attorney, particularly in respect of his life sciences EPO opposition practice.

Simon entered the profession in 2008 and joined UDL in 2015. He became a partner in 2018.

Our people

Articles by Dr Simon Mitchell



​Patentability of plants or animals — the Boards of Appeal of the EPO Boards of Appeal assert authority

A new EPO decision clarifies aspects of its position, but leaves many questions unanswered...

Read more



Microbiome inventions — patenting the gastric microbes that keep you healthy

Dr Simon Mitchell considers microbiome inventions at the European Patent Office.

Read more



CRISPR-Cas9 – from gene editing to EPO patent law editing?

Getting filing formalities correct is just as important as getting the science correct...

Read more

Website by Extreme